Raynaud phenomenon in systemic sclerosis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Start a dihydropyridine calcium-channel blocker
A calcium-channel blocker such as nifedipine is standard first-line drug therapy for Raynaud symptoms in systemic sclerosis when conservative measures are insufficient. Warfarin and immediate sympathectomy are inappropriate for uncomplicated Raynaud symptoms. Digital ulcers or critical ischaemia would require escalation and vascular assessment.
Reference: BSR systemic sclerosis guideline; EULAR systemic sclerosis recommendations